secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001654954-23-010854
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics amends bylaws to lower quorum to one-third, allow director removal without cause
--------------------------------------------------------------------------------

- Quorum for stockholder meetings reduced to one-third of shares entitled to vote from previous higher threshold.
- Directors may now be removed with or without cause by majority vote of stockholders.
- Amended bylaws add provisions clarifying mechanics for adjourning stockholder meetings.
- Other ministerial, clarifying and conforming changes were included in the Fourth Amended and Restated Bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495423010854/0001654954-23-010854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495423010854/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-010854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer